Lund-based Abliva AB named Dr Ellen Donnelly as its new CEO. At the beginning of February she succeeded Dr Erik Kinnmann, who had been CEO since 2018.

Märta Segerdahl will take over the position as Chief Medical Officer of Swedish AlzeCure Pharma AB on April.

Spanish Accure Therapeutics appoints Dr Rossella Medori as new Chief Medical officer.

Muttenz-based Clariant announced the appointment of Conrad Keijzer as new Chief Executive Officer,

Strasbourg-based Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer.

Bart Wuurman joined the young Belgian biotechnology company Apaxen S.A. in November as new CEO.

French Polyplus-transfection SA named Mario Philips as new CEO. He succeeds Karsten Wilking, now a Strategic Advisor of the biotech company, specialist for innovative transfection solutions to support the gene and cell therapy market.

Thomas Struckmeyer will join the BioChek Group based in Reeuwijk as new CEO from mid-December. He succeeds Barend van Dam, who will assume the position of CEO of the BioChek Group.

Claire Skentelbery, well known and connected in the European biotech community, will be the new Director General of EuropaBio. She will join the EuropaBio team at the end of November.

Melanie Leveridge takes over the lead of the European Laboratory Research & Innovation Group (ELRIG) UK to drive further collaboration between academia and biopharma industry.